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Introduction
　Only 30 cases of non-invasive （intra-capsular） carcinoma ex pleomorphic adenoma have 
been reported in the English language literature1-5）.  Here, we report three cases of noninva-
sive carcinoma ex pleomorphic adenoma and we have carried out a literature survey.
Case Reports （Table 1-1, 1-2）
Case 1
　A 61-year-old man was admitted to hospital, presenting with a mass in the parotid gland. 
The mass was not painful and had been present for about twenty years without affecting 
normal facial nerve function.  Computed tomography revealed a solitary, well-demarcated 
solid tumor without calcication, measuring 45 mm in its largest dimension in the antero-
lateral aspect of the left parotid gland.  Fine needle aspiration cytology revealed malignant 
cells, and a parotidectomy was performed for complete resection of the tumor.  No nodal 
involvement was observed and the patient received no subsequent chemotherapy or radio-
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therapy.  The patient was monitored and remained well and without evidence of disease for 
70 months after the surgery.
Case 2
　A 72-year-old man was admitted to hospital, presenting with a non-painful mass in the 
Table 1-1　Clinicopathological features of non-invasive carcinoma ex Pleomorphic adenoma in the literature
literature case sex age Site Duration TNM/stage Size（diameter in mm）
Brandwein ［2］ 1 F 41 Parotid gland  2 months T1N0M0 17
2 M 64 Submandibular gland Unknown T2N0M0 28
3 M 44 UN 18 months T1N0M0 17.5
4 F 65 Parotid gland Unknown T2N0M0 28
5 M 34 Parotid gland 18 months T2N0M0 23
6 F 73 Parotid gland 10 years T1N0M0 12
7 M 50 Parotid gland  4 months T1N0M0 15
8 M 61 Parotid gland Months T2N0M0 35
9 F 74 Submandibular gland Months T1N0M0  8
10 F 35 Submandibular gland  3 months T1N0M0 10
11 F 69 Parotid gland  4 months T1N0M0 20
12 F 59 Parotid gland 12 years T1N0M0 15
Lewis ［4］ 13 UN UN UN UN UN UN
14 UN UN UN UN UN UN
15 UN UN UN UN UN UN
16 UN UN UN UN UN UN
Felix ［3］ 17 F 57 Parotid gland 10 months T3N1M0 40
Di palma ［7］ 18 M 50 Parapharyngeal region  5 years T2aN0M0 65
19 F 56 Parotid gland unknown T1aN0M0 20
20 M 44 Parotid gland 10 years T2aN0M0 35
21 F 72 Parotid gland unknown T2aN0M0 22
22 M 68 Parotid gland unknown T2aN0M0 40
23 F 69 Submandibular gland  2 years T2aN0M0 25
24 F 54 Parotid gland unknown T1aN0M0 40
25 M 75 Parotid gland unknown T2aN0M0 25
26 M 73 Parotid gland unknown T2aN0M0 15
27 M 54 Parotid gland unknown T1aN0M0 19
28 M 71 Parotid gland 42 years T1aN0M0 30
Ethunandan ［1］ 29 F 59 Parotid gland unknown T2N0Mo 25
30 M 77 Parotid gland  5 months T1N0M0 20
Present cases 31 M 61 Parotid gland 20 years T2N0M0 25
32 M 62 Parotid gland  4 years T2N0M0 35
33 M 57 Parotid gland many years T2N0M0 40
CXPA : carcinoma ex PA NED : no evidence of disease SMGE : Sub-mandibular gland excision
PA : pleomorphic adenoma PND : partial neck disection SP : Supercial conservative parotidectomy
UN : unknown TP : total parotidectomy RD : radial parotidectomy
 PP : profunda parotidectomy CP : conservative parotidectomy
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Brandwein ［2］ 1 UN NED UN 5 years UN
2 UN NED UN 3 years UN
3 UN NED UN 3 years UN
4 UN NED UN 13 years UN
5 UN NED UN 9 years UN
6 UN NED UN 4 years UN
7 UN NED UN 4 years UN
8 UN NED UN 3 years UN
9 UN NED UN 3 years UN
10 UN NED UN  1.2 years UN
11 UN NED UN 1 year UN
12 UN NED UN 1 year UN
Lewis ［4］ 13 UN NED adenocarcinoma NOS UN UN
14 UN NED adenocarcinoma NOS UN UN
15 UN NED adenocarcinoma NOS UN UN
16 UN NED salivary duct carcinoma UN UN
Felix ［3］ 17 TP＋ cervical 
lymphadenectomy＋
radiotherapy 50Gy
NED high grade adenocarcinoma 36 months UN
Di palma ［7］ 18 RP NED UN 12 months UN
19 SP NED low grade spindle cell 
myoepithelial CXPA
12 months 1
20 SP NED UN 24 months 3
21 SP NED UN 3 years 2
22 SP NED high grade spindle cell 
myoepithelial CXPA
3 years 0
23 Resection NED UN 6 years 3
24 SP NED UN 1 years 3
25 SP＋ PND NED UN 1 years 3
26 CP NED UN 2 years 2
27 CP NED UN 2 years 3
28 CP NED UN 2 years 3
Ethunandan ［1］ 29 SMGE NED UN 15 months UN
30 SP NED salivary duct carcinoma 36 months UN
Present cases 31 SP NED adenocarcinoma NOS  5 years
10 months
2
32 PP NED adenocarcinoma NOS  3 years
1 month
2
33 SP NED adenocarcinoma NOS 36 months 2
CXPA : carcinoma ex PA NED : no evidence of disease SMGE : Sub-mandibular gland excision
PA : pleomorphic adenoma PND : partial neck disection SP : Supercial conservative parotidectomy
UN : unknown TP : total parotidectomy RD : radial parotidectomy
 PP : profunda parotidectomy CP : conservative parotidectomy
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parotid gland, which had been present for four years and with normal facial nerve function. 
Computed tomography revealed a well-demarcated solid tumor without calcication, measur-
ing 30 mm in its largest dimension in the lateral aspect of the right parotid gland.  Magnetic 
resonance imaging revealed capsular invasion but fine needle aspiration cytology did not 
reveal malignant cells.  A clinical diagnosis of pleomorphic adenoma was made.  Profunda 
parotidectomy was performed.  No nodal involvement was observed and the patient received 
no subsequent chemotherapy or radiotherapy.  The patient was monitored and remained well 
and without evidence of disease for 37 months after the surgery.
Case 3
　A 57-year-old man was admitted to hospital, presenting with a non-painful mass of the 
parotid gland that was present for many years with normal facial nerve function.  Com-
puted tomography revealed a solitary, well-demarcated solid tumor without calcification, 
measuring 25 mm in its largest dimension in the inferior aspect of the left parotid gland. 
A clinical diagnosis of pleomorphic adenoma of the parotid gland was made.  Supercial 
parotidectomy was performed and no nodal involvement observed.  The patient received no 
chemotherapy or radiotherapy and was well without evidence of the disease 36 months after 
the surgery.
Histopathological ndings （Figs. 1, 2, 3）
　The resected parotid tissues were 70×45×15 mm in Case 1, 35×30×22 mm in Case 
2, and 40 × 35 × 20 mm in Case 3.  Histological analysis of sections of the resected tissues 
revealed well-demarcated nodular tumors, measuring 25 mm in Case 1 （Fig. 1-A）, 35 mm in 
Case 2 （Fig. 2-A）, and 25 mm in Case 3 （Fig. 3-A）.  All three tumors were solid, hard and 
myxomatous and appeared grayish-white without necrotic foci or hemorrhage.  Microscopic 
observation of the tumors showed well-circumscribed pleomorphic adenoma surrounded by 
a brous capsule, which was not invaded by the tumor （Figs. 1-B, 2-B, 3-B）.  In addition 
to the presence of denite benign areas, there was a diffuse area showing carcinomatous 
changes occupying 30% in Case 1, 20% in Case 2, and 50% in Case 3.  These changes 
included cells exhibiting an eosinophilic cytoplasm, atypical nuclei, prominent nucleoli （Figs. 
1-C, 2-C, 3-C）, and mitosis.  These features were similar to those of an adenocarcinoma not 
otherwise specied.  Malignant tubules and benign ducts, which were associated with benign-
looking myoepithelial cells, showed transitional features.  There was no evidence of vascular 
or perineural invasion, and careful examination of serial sections of the entire capsule 
revealed that the tumors were conned by capsular tissue.  There was no nodal involve-
ment and the tumors were diagnosed as noninvasive carcinoma ex pleomorphic adenoma. 
Immunohistochemical analysis for HER-2/neu showed that carcinoma foci were moderately 
positive, but adenoma foci were completely negative （Figs. 1-D, 2-D, 3-D）.
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Discussion
　Pleomorphic adenoma is the most common salivary gland neoplasm ;  it infrequently 
undergoes malignant transformation.  The propensity for malignant transformation by either 
clinical or histological criteria is 1.9-23.3% and carcinoma ex pleomorphic adenoma repre-
sents approximately 12% of all malignant salivary gland tumors 4，5）.  Although the ratio of 
malignant transformation is unclear in the salivary gland tumors we have examined in the 
last 10 years, we identied 155 pleomorphic adenomas and 15 carcinoma ex pleomorphic 
adenomas.  Carcinoma ex pleomorphic adenomas are generally divided into three histo-
pathological types : noninvasive, minimally invasive （less than 1.5 mm of invasion beyond 
the lesional capsule）, and invasive type6）.  In our 15 cases of carcinoma ex pleomorphic 
adenoma, three cases of noninvasive type, no case of minimally invasive type, and 12 cases 
Fig. 1.  Histopathologic ndings of Case 1
A :  Upon sectioning, the tumor was found to be solid, hard, and white without necrotic foci or 
hemorrhage
B :  The tumor is surrounded by a brous capsule, and there is no evidence of capsular invasion.（original 
magnication × 1.25）
C :  Adenocarcinoma is noted on the right side of the eld, and pleomorphic adenoma is noted on the 
left side of the eld. （original magnication ×20）
D :  HER-2/neu expression is observed in adenocarcinoma （right side of the eld）, and is not observed 
in adenoma （left side of the eld）.（original magnication ×20）
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of invasive type were included.
　Thirty cases of noninvasive （intracapsular） carcinoma ex pleomorphic adenoma have been 
reported previously but the features of four of those cases were not reported in detail 2-5，7，8）. 
We compared the clinical pathologic features of 30 cases previously reported with the three 
cases reported here （Table 1-1, 2）.  Of the cases with known gender, these represented 
16 males and 13 females, with a mean age of 59.6 years （range, 34-77）.  The duration 
between tumor discovery and surgery ranged from two months to many years.  Two of the 
female patients had prior irradiation directed at the head.  Twenty-three tumors involved the 
parotid gland, four tumors involved the submandibular gland, and one tumor involved the 
parapharyngeal region.  In the remaining cases, the regions affected by the tumor were not 
documented.  The diameter of the tumors ranged from 8 mm to 40 mm （mean, 25.8 mm）.
　The method of treatment included : supercial conservative parotidectomy in eight cases, 
Fig. 2.  Histopathologic ndings of case 2
A :  On sectioning, the tumor is solid, hard, myxomatous and it appears citrine without necrotic foci or 
hemorrhage.
B :  The tumor is surrounded by a fibrous capsule, and there is no evidence of capsular invasion. 
（original magnication ×1.25）
C :  Adenocarcinoma is seen, and some mitotic gures are observed （arrows）.（original magnication ×20）
D :  HER-2/neu expression is observed in adenocarcinoma （ left side of the eld）, and is not observed 
in adenoma （right side of the eld）.（original magnication ×20）
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conservative parotidectomy in three cases, sub-mandibular gland excision in one case, super-
cial conservative parotidectomy and partial neck dissection in one case, total parotideatomy 
and cervical lymphadenectomy in one case, and profunda parotidectomy in one case.  The 
treatments in other 14 cases were not documented.  The follow -up periods ranged from 4 
months to 13 years （mean range, 38.6 months）.  Only one of the 33 patients showed recur-
rence or metastasis after surgery most likely as a result of benign pleomorphic adenoma3）.
　HER-2/neu expression, which is a marker of malignant salivary gland tumors, was exam-
ined in a total of 14 cases, including 11 previous cases and the three cases reported in this 
study.  Twelve cases were positive for HER-2/neu and the two negative cases were non-
invasive myoepithelial carcinoma ex pleomorphic adenoma cases arising in myoepithelial 
cells.
　We conclude that pleomorphic adenoma with focal areas showing malignant changes 
Fig. 3.  Histopathologic ndings of case 3
A :  Upon sectioning, the tumor was found to be solid, hard, myxomatous, and it appears grayish-white 
without necrotic foci or hemorrhage.
B :  The tumor is surrounded by a brous capsule and there is no evidence of capsular invasion.（original 
magnication × 1.25）
C :  Adenocarcinoma is noted on the right side of the eld, and pleomorphic adenoma is noted on the 
left side of the eld. （original magnication ×20）
D :  HER-2/neu expression is observed in adenocarcinoma （right side of the eld）, and is not observed 
in adenoma （left side of the eld）.（original magnication ×20）
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should be carefully assessed by serial sectioning to obtain evidence of capsular invasion, 
which agrees with previous reports 2，5）.  The prognosis and therapeutic approach depend on 
the evidence of capsular invasion.  HER-2/neu is a useful marker in the differential diagno-
sis of pleomorphic adenoma versus noninvasive carcinoma ex pleomorphic adenoma.  This is 
especially true when there a suspicion that the pleomorphic adenoma includes a malignant 
component or shows malignant transformation 7）.  Recent studies have revealed that the 
androgen receptor （AR）, Ki-67, and p53 may also be useful markers for this differential 
diagnosis, although they were not examined in this study.
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